Patents by Inventor Jason O'Connor

Jason O'Connor has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220023536
    Abstract: Disclosed are techniques and a device operable to determine a total amount of insulin delivered to the user over a predetermined time period. The total amount of insulin includes a total basal dosage delivered in basal dosages and a total bolus dosage delivered in bolus dosages over the predetermined time period. A proportion of the total amount of insulin delivered to the user provided via the total basal dosage amount over the predetermined time period is calculated. In response determining the proportion of the total amount of insulin attributed to the total basal dosage amount of insulin exceeds a threshold, an average basal dosage to be delivered within a subsequent time period that is approximately equal to the threshold may be determined. An instruction may be generated and output to deliver a modified basal dosage that substantially maintains the average basal dosage over the subsequent time period.
    Type: Application
    Filed: July 16, 2021
    Publication date: January 27, 2022
    Inventors: James GRAHAM, Joon Bok LEE, Jason O'CONNOR
  • Patent number: 11208379
    Abstract: Some embodiments of the invention include inventive compounds (e.g., compounds of Formula (I) or (Ia)). Other embodiments include compositions (e.g., pharmaceutical compositions) comprising the inventive compound. Still other embodiments of the invention include compositions (e.g., pharmaceutical compositions) for treating, for example, certain diseases using the inventive compounds. Some embodiments include methods of using the inventive compound (e.g., in compositions or in pharmaceutical compositions) for administering and treating (e.g., diseases such as cancer). Further embodiments include methods for making the inventive compounds. Additional embodiments of the invention are also discussed herein.
    Type: Grant
    Filed: November 3, 2019
    Date of Patent: December 28, 2021
    Assignee: UNIVERSITY OF LOUISVILLE RESEARCH FOUNDATION, INC.
    Inventors: Craig A. Grapperhaus, Robert M. Buchanan, Nicholas S. Vishnosky, Jason O. E. Young, Paula J. Bates, Sarah A. Andres, Caleb Aaron Calvary
  • Patent number: 11206677
    Abstract: Vehicles, media, and methods are provided for sharing vehicle map data over transmission media selected according to urgency of the map data. One vehicle includes a hardware processor; and a non-transitory machine-readable storage medium encoded with instructions executable by the hardware processor to perform a method comprising: receiving information relating to a road; determining an urgency level of the information; selecting one of a plurality of transmission media according to the determined urgency level; and transmitting the information over the selected transmission medium.
    Type: Grant
    Filed: August 14, 2019
    Date of Patent: December 21, 2021
    Assignee: TOYOTA MOTOR NORTH AMERICA, INC.
    Inventors: Louis Anthony Brugman, Jason O. Schell
  • Publication number: 20210387417
    Abstract: An additive manufacturing system has a controller configured to modify numerical control programming instructions to form interlocking structures that improve object structural integrity in the Z-direction. The interlocking structures are produced by forming one layer with swaths that are separated by gaps and another layer that is formed over the gaps to fill the gaps and lay over the swaths forming the gaps.
    Type: Application
    Filed: June 10, 2020
    Publication date: December 16, 2021
    Inventors: David A. Mantell, Christopher G. Lynn, Jason O'Neil, Priyaanka D. Guggilapu, Peter J. Nystrom
  • Publication number: 20210379282
    Abstract: Systems and methods for automatically delivering medication to a user. An automated drug delivery system may include a sensor and a wearable automated drug delivery device. The wearable automated drug delivery device may be configured to couple to the skin of a user and may include a controller and a pump. The pump may be configured to output the medication. The controller may be within the wearable automated drug delivery device. The sensor may be coupled to the user and may be configured to collect information regarding the user. The controller of the wearable automated drug delivery device may use the collected information to locally determine an amount of medication to be output from the wearable automated drug delivery device and cause delivery of the amount of medication.
    Type: Application
    Filed: August 16, 2021
    Publication date: December 9, 2021
    Inventors: Jason O'CONNOR, Daniel ALLIS, David NAZZARO, John R. Bussiere, John D'ARCO
  • Publication number: 20210367542
    Abstract: A motorized window treatment may be configured to adjust a position of a covering material to control the amount of daylight entering a space. The motorized window treatment may include a DC power source for charging an energy storage element, such as a supercapacitor and/or rechargeable battery. The energy storage element may be configured to provide power for the operation of a motor used to adjust the position of the covering material. The energy storage element may discharge when providing power to the motor and may charge such that the current it draws from a battery is at a desired average current level that extends the lifetime of the battery.
    Type: Application
    Filed: May 21, 2021
    Publication date: November 25, 2021
    Applicant: Lutron Technology Company LLC
    Inventors: Jason O. Adams, Edward J. Blair, Stuart W. DeJonge, Olli T. Friman
  • Patent number: 11152795
    Abstract: Systems and methods for providing federated power management in an electronic circuit. The methods comprise: performing first operations by a processing device to obtain information indicating a current level of charge for each of a plurality of capacitors which have been supplied energy from a power source; transforming, by the processing device, each capacitor's current level of charge into a number of service units for a respective electronic load device of a plurality of electronic load devices; determining, by the processing device, at least one of recharging priorities for the plurality of capacitors and discharging priorities for the plurality of capacitors at least based on the results of said transforming; and performing second operations by the processing device to cause the plurality of capacitors to be recharged in accordance with the recharging priorities or discharged in accordance with the discharging priorities.
    Type: Grant
    Filed: March 28, 2018
    Date of Patent: October 19, 2021
    Assignee: FLORIDA ATLANTIC UNIVERSITY BOARD OF TRUSTEES
    Inventors: Jason O. Hallstrom, Jiannan Zhai, Chancey Kelley, Michael Brown, Alexander Roscoe
  • Patent number: 11143958
    Abstract: A process including providing a substantially flat printed image on a substrate; disposing a curable gellant composition onto the printed image in registration with the printed image, successively depositing additional amounts of the gellant composition to create a raised image in registration with the printed image; and curing the deposited raised image. A process including providing a printed image on a substrate; disposing a curable non-gellant composition onto the printed image in registration with the printed image; and disposing a curable gellant composition onto the printed image in registration with the printed image; to create a raised image in registration with the printed image; and curing the deposited raised image. An ultraviolet curable phase change gellant composition including a radiation curable monomer or prepolymer, a photoinitiator, a silicone polymer or pre-polymer, and a gellant.
    Type: Grant
    Filed: April 4, 2018
    Date of Patent: October 12, 2021
    Assignee: Xerox Corporation
    Inventors: Jennifer L. Belelie, Michelle N. Chrétien, Paul J. McConville, Jason O'Neil, Barkev Keoshkerian, Anthony S. Condello
  • Publication number: 20210308377
    Abstract: Disclosed are techniques to establish initial settings for an automatic insulin delivery device. An adjusted total daily insulin (TDI) factor usable to calculate a TDI dosage may be determined. The adjusted TDI factor may be a TDI per unit of a physical characteristic of the user (e.g., weight) times a reduction factor. The adjusted TDI factor may be compared to a maximum algorithm delivery threshold. Based on the comparison result, the application or algorithm may set a TDI dosage and output a control signal. Blood glucose measurement values may be collected from a sensor over a period of time. A level of glycated hemoglobin of the blood may be determined based on the obtained blood glucose measurement values. In response to the level of glycated hemoglobin, the set TDI dosage may be modified. A subsequent control signal including the modified TDI dosage may be output to actuate delivery of insulin.
    Type: Application
    Filed: April 6, 2020
    Publication date: October 7, 2021
    Inventors: Mengdi LI, Joon Bok LEE, Jason O'CONNOR, Yibin ZHENG
  • Publication number: 20210313037
    Abstract: A system, techniques, and computer-readable media includes examples that provide an indication of an early exercise detection are described. An example of an early exercise detection application executed by a processor may cause the processor to perform functions and be operable to obtain image data including metadata from a camera of a mobile device during, for example, an unlock procedure of a mobile device. The processor may determine whether the obtained image data includes location or timestamp information in metadata or has image data that may be recognized as exercise-related objects. Based on the determinations, the processor may output an indication of early exercise detection to an artificial pancreas application, which is operable to adjust an amount of insulin to be delivered to a user.
    Type: Application
    Filed: April 6, 2020
    Publication date: October 7, 2021
    Inventors: Jason O'CONNOR, Ian MCLAUGHLIN, Daniel ALLIS, Paul Frederick BENTE, IV, Steven CARDINALI, Joon Bok LEE
  • Publication number: 20210293781
    Abstract: A method for separating particles in a biofluid includes pretreating the biofluid by introducing an additive, flowing the pretreated biofluid through a microfluidic separation channel, and applying acoustic energy to the microfluidic separation channel. A system for microfluidic separation, capable of separating target particles from non-target particles in a biofluid includes at least one microfluidic separation channel, a source of biofluid, a source of additive, and at least one acoustic transducer coupled to the microfluidic separation channel. A kit for microfluidic particle separation includes a microfluidic separation channel connected to an acoustic transducer, a source of an additive, and instructions for use.
    Type: Application
    Filed: February 9, 2021
    Publication date: September 23, 2021
    Inventors: Jason O. Fiering, Kenneth T. Kotz
  • Publication number: 20210276254
    Abstract: An additive manufacturing system has a controller configured to operate an actuator to move a multi-nozzle extruder in an XY plane and rotate the multi-nozzle extruder about an axis perpendicular to the XY plane while operating the multi-nozzle extruder to form swaths in the XY plane. The controller operates the actuator and the multi-nozzle extruder to keep the nozzles of the extruder within perimeters formed for an object and to vary the speed and rotation of the extruder while extruding material to form precise structures.
    Type: Application
    Filed: March 9, 2020
    Publication date: September 9, 2021
    Inventors: David A. Mantell, Christopher G. Lynn, Jason O'Neil, Priyaanka D. Guggilapu, Peter J. Nystrom
  • Publication number: 20210252219
    Abstract: Exemplary embodiments may address the problem of missing blood glucose concentration readings from a glucose monitor that transmits blood glucose concentration readings over a wireless connection due to problems with the wireless connection. In the exemplary embodiments, an automated insulin delivery (AID) device uses an estimate in place of a missing blood glucose concentration reading in determining a predicted future blood glucose concentration reading for a user. Thus, the AID device is able to operate normally in generating insulin delivery settings despite not receiving a current blood glucose concentration reading for a current cycle. There is no need to suspend delivery of insulin to the user due to the missing blood glucose concentration reading.
    Type: Application
    Filed: February 14, 2020
    Publication date: August 19, 2021
    Applicant: INSULET CORPORATION
    Inventors: Yibin ZHENG, Joon Bok LEE, Ashutosh ZADE, Jason O'Connor
  • Patent number: 11090434
    Abstract: Systems and methods for automatically delivering medication to a user. An automated drug delivery system may include a sensor and a wearable automated drug delivery device. The wearable automated drug delivery device may be configured to couple to the skin of a user and may include a controller and a pump. The pump may be configured to output the medication. The controller may be within the wearable automated drug delivery device. The sensor may be coupled to the user and may be configured to collect information regarding the user. The controller of the wearable automated drug delivery device may use the collected information to locally determine an amount of medication to be output from the wearable automated drug delivery device and cause delivery of the amount of medication.
    Type: Grant
    Filed: October 23, 2020
    Date of Patent: August 17, 2021
    Assignee: INSULET CORPORATION
    Inventors: Jason O'Connor, Daniel Allis, David Nazzaro, John R. Bussiere, John D'Arco
  • Publication number: 20210249115
    Abstract: Disclosed are examples of a device, a system, methods and computer-readable medium products operable to implement functionality to determine and respond to a purpose of a meal. An algorithm or application may receive data that may include data related to a meal purpose from data sources and determine whether any of the data received from the plurality of data sources was received from a direct data source or an indirect data source. The data may be evaluated to determine a purpose of the meal. Based on the results of the evaluation, instructions may be generated to provide an appropriate response based on the determined purpose of the meal. The generated instructions to provide the appropriate response based on the determined purpose of the meal may be output.
    Type: Application
    Filed: February 11, 2020
    Publication date: August 12, 2021
    Inventors: David NAZZARO, Steven CARDINALI, Nicholas CONTE, Daniel ALLIS, Jason O'CONNOR, Joon Bok LEE, Ashutosh ZADE, Timothy HENNING, Thomas METZMAKER, Ian MCLAUGHLIN
  • Publication number: 20210244880
    Abstract: The exemplary embodiments attempt to identify impending hypoglycemia and/or hyperglycemia and take measures to prevent the hypoglycemia or hyperglycemia. Exemplary embodiments may provide a drug delivery system for delivering insulin and glucagon as needed by a user of the drug delivery system. The drug delivery system may deploy a control system that controls the automated delivery of insulin and glucagon to a patient by the drug delivery system. The control system seeks among other goals to avoid the user experiencing hypoglycemia or hyperglycemia. The control system may employ a clinical decision support algorithm as is described below to control delivery of insulin and glucagon to reduce the risk of hypoglycemia or hyperglycemia and to provide alerts to the user when needed. The control system assesses whether the drug delivery system can respond enough to avoid hypoglycemia or hyperglycemia and generates alerts when manual action is needed to avoid hypoglycemia or hyperglycemia.
    Type: Application
    Filed: February 12, 2020
    Publication date: August 12, 2021
    Applicant: INSULET CORPORATION
    Inventors: Joon Bok LEE, Ashutosh ZADE, Jason O'CONNOR, Trang LY, Yibin ZHENG, Connor GULLIFER, Kyle GROVER
  • Publication number: 20210244881
    Abstract: Exemplary embodiments described herein relate to a closed loop artificial pancreas system. The artificial pancreas system seeks to automatically and continuously control the blood glucose level of a user by emulating the endocrine functionality of a healthy pancreas. The artificial pancreas system uses a closed loop control system with a cost function. The penalty function helps to bound the infusion rate of insulin to attempt to avoid hypoglycemia and hyperglycemia. However, unlike conventional systems that use a generic or baseline parameter for a user's insulin needs in a cost function, the exemplary embodiments may use a customized parameter in the cost function that reflects the individualized insulin needs of the user. The use of the customized parameter causes the cost function to result in insulin dosages over time better suited to the individualized insulin needs of the user. This helps to better avoid hypoglycemia and hyperglycemia.
    Type: Application
    Filed: February 12, 2020
    Publication date: August 12, 2021
    Applicant: INSULET CORPORATION
    Inventors: Joon Bok LEE, Yibin ZHENG, Jason O'CONNOR
  • Publication number: 20210236726
    Abstract: Exemplary embodiments may provide an improved approach to automated insulin delivery by more accurately estimating the total daily insulin (TDI) of a user. As a result, less insulin is wasted by the delivery system, and the estimate of TDI more closely matches a user's actual daily insulin needs. Hence, the user need not refill the insulin reservoir excessively or need not fret unnecessarily about running out of insulin prematurely. The estimate relies on the history of actual automated insulin deliveries and thus reflects the actual insulin delivered to the user more accurately than conventional approaches.
    Type: Application
    Filed: February 3, 2020
    Publication date: August 5, 2021
    Applicant: INSULET CORPORATION
    Inventors: Steven CARDINALI, Ashutosh ZADE, Joon Bok LEE, Jason O'CONNOR, Yibin ZHENG
  • Publication number: 20210236730
    Abstract: In an automated insulin delivery device, fuzzy logic may be applied to the responding to the possibility of a user taking additional action that may affect the blood glucose concentration. Fuzzy sets may be defined for empirically derived different likelihoods of the user taking such additional action based on correlated factors. A membership function may be provided for each fuzzy set. The membership function may provide a probability of membership in the set based on a parameter. Each fuzzy set may have a response that is reflective of the likelihood of additional user action associated with the fuzzy set. The responses by the AID device to each of these cases may reflect the probability of each such case occurring as evidenced by empirical data.
    Type: Application
    Filed: February 3, 2021
    Publication date: August 5, 2021
    Applicant: INSULET CORPORATION
    Inventors: Joon Bok LEE, Ashutosh ZADE, Jason O'CONNOR, Yibin ZHENG, Steven CARDINALI
  • Patent number: D937497
    Type: Grant
    Filed: January 18, 2019
    Date of Patent: November 30, 2021
    Assignee: GENTEX CORPORATION
    Inventors: Emily Hancock, Jason O'Connell